Connect with us

Defective Products

Reynolds American Seeks FDA Review for Vuse

mm

Published

on

Reynolds American Inc. filed for a review with the FDA for a review of Vuse, an e-cigarette manufactured by the company. The main rival for Vuse is Juul Labs Inc. which has the leading share of the market. However, this review application could give the company an edge over Juul.

Challenges for the Vaping Industry

The US Food and Drug Administration had set a deadline for May 2020 for manufacturers of e-cigarettes and vaping devices to submit a formal application. The application is a request to keep the products on the market while preventing the use of e-cigarettes by those who are underage.

The Vuse e-cigarette provides nicotine to users through a vapor system with cartridges. Reynolds provided the FDA with the detailed design and manufacturing process as well as data on safety of the product. It resulted in more than 150,000 pages of documents.

E-cigarette manufacturers are required to submit these applications for a review if they want to keep their products on the market. The agency is attempting to figure out the best way to monitor the manufacturing as well as the marketing of the products.

The changes come as a result of the outbreak of a lung illness that has been linked to vaping. At least 29 people have died and another 1300 have contracted the disease. It has also been an issue with the rise of teen vaping as manufacturers appear to be marketing to this segment even though they cannot legally purchase the product.

Taking Action to Protect the Public

Companies like Juul Labs have suffered because of the illness, which has not only affected adults but those who are under the age of 18. One person under that age has died from the illness. Critics have said that Juul marketed to teens by creating ads that would appeal to that age range and by using flavors which are geared towards that segment of the market, such as bubble gum and fruit flavors.

The federal government has developed a plan to remove all flavored e-cigarettes from stores, including those with menthol. Allegations abound that e-cigarette use leads to nicotine addiction and can even cause addiction to other substances. While the manufacturers say that the products were designed as an alternative to tobacco for smokers, many non-smokers have began vaping. Some studies indicate that the nicotine in the products could lead to addiction.

Another concern is that people are buying the vaping products off the street or adding their own chemicals instead of using what is included with the product. THC, an active ingredient in marijuana, is in many of the devices. It is also being linked with a majority of the illnesses. While investigators cannot say for certain that the substance is the cause of the lung disease, they do warn people to be cautious when vaping. In fact, they recommend not vaping at all until an exact cause can be determined.

With Reynolds submitting a formal application, it places them in a good position to increase their share of the market with Vuse over Juul.

Comments

Defective Products

Bayer Settles 90% of U.S. Essure Claims for 1.6 Billion

mm

Published

on

About 90 percent of the more than 39,000 lawsuits filed against Bayer over Essure injuries have been resolved by a $1.6 billion settlement. Bayer said in a statement that the settlement resolves most filed and unfiled cases and that it continues to work with plaintiff’s lawyers to resolve the remaining cases.

FDA Actions and Essure Injury Complaints

The settlement comes after years of complains of adverse events involving the metal coils which are placed in the fallopian tubes. Some of these complaints say that the coils can perforate the tubes, tear the uterus, and that the coils can break causing little metal shards to migrate elsewhere in the body. Women have also complained of heavy bleeding, pain, and other side effects that the patients were forced to undergo hysterectomy.

In 2018, the U.S. Food and Drug Administration placed restrictions on the device and required patients to review the Patient- Doctor Discussion Checklist and sign prior to being implanted with the birth control device. Bayer made the decision to stop selling Essure in the United States not long after citing declining sales.

Post-Market Surveillance Reports

The required 522 study, a post-marketing surveillance plan, was also extended by the FDA from three to five years. The FDA published the first spreadsheet of Essure adverse events on August 11, 2020, which includes events that Bayer knew or learns of during the period of November 2016 to November 2020.

The first spreadsheet includes more than 1,400 events including pain, device fragments, pregnancy, and organ perforations, including 1376 reports of serious injury, 53 reports of death and 24 reports of malfunction.

Essure Lawsuit Settlement

Many of the plaintiffs alleged in court filings that Bayer knew or should have known about the risk of adverse events, including organ perforation, device breakage, and device migration. They also allege that Essure birth control was improperly design and can break and migrate after being implanted. They accused Bayer of misrepresenting the efficacy and safety of the contraceptive device and Women who suffered Essure injuries alleged in court filings that Bayer concealed the risks and dangers of the device from the FDA, the medical community and from the women who relied on the device.

Many of the terms of the settlement are confidential, and Bayer did not admit to any wrongdoing in the court filings.

Comments
Continue Reading

Covid-19

Risk for COVID-19 Goes Up for Vapers

mm

Published

on

A new study shows the correlation between COVID-19 and young adults who are vaping. This includes teens as well. According to the study, the risk for developing the infection was five times higher if the person vaped regularly.

The study also indicated an increase of seven times the risk for young adults who vape and smoke tobacco cigarettes. The study was published in the Journal of Adolescent Health. Because of this information, the government has asked the US Food and Drug Administration (FDA) to remove all e-cigarettes from the market until after the pandemic has been dealt with.

E-cigarettes and Damage to the Lungs

Experts are concerned about the high numbers. They want young adults and teens to be aware that e-cigarettes and vaping devices aren’t safe. They come with serious harm that is real.

The evidence isn’t astounding, but it is important. It is well-known that e-cigarettes can harm the lungs as well as the immune system. In 2019, there were numerous cases of a mysterious lung illness associated with vaping. Many people got sick from the illness after vaping, and several people died.

There is another correlation between vaping and COVID-19. According to researchers, the SARS-CoV-2 virus that causes COVID-19 needs a pathway to get into the body’s cells. It is believed that e-cigarettes might make the pathway easier to access.

Another risk is that teens and young adults often share vaping devices. If one person is positive for COVID-19, the next person using that device could become infected as they inhale the virus right into their lungs. Exhaling from the vaping device could also cause people nearby to become infected.

The government is interceding in light of this news. The Subcommittee from the US House Committee on Oversight and Reform is calling on the FDA to get these products out of the hands of consumers. The subcommittee is the Economic and Consumer Policy.

This information goes along with a study from China that showed smokers in that country developed more serious symptoms and had to be hospitalized more often than other patients.

Young People Who Vape and Smoke are At Risk

An online survey was handed out in early May to teens and young adults under the age of 25. About half of the 4300 surveyed admitted to using e-cigarettes. The study showed that those who vaped had about three times the likelihood for being tested for COVID-19. Those who vaped and smoked had a five times higher rate of developing symptoms of the virus. These symptoms include coughing and fever as well as difficulty breathing and feeling fatigued.

Many young adults are already hooked on vaping and e-cigarettes. However, there are some programs that are tailored just for younger adults.

Some researchers also say that a direct correlation between e-cigarettes and COVID-19 hasn’t been made. While they believe that tobacco products do cause damage to the respiratory system and increase the infection rate, they cannot say for a fact that it causes an increased risk directly. However, all can agree that it appears that those young people who are using e-cigarettes are at a high risk for developing the coronavirus and possible complications.

Comments
Continue Reading

Defective Products

FDA Sets Limit for Acceptable Amount of Arsenic in Baby Cereal

mm

Published

on

Cereal can contain arsenic from the grains it uses, but rice cereals are often higher in this toxic substance. The FDA has issued a limit for the amount of arsenic that can be found in rice cereal for infants. It is the first limit the agency has set up for arsenic in any food.

Arsenic in Baby Cereal

Rice is a grain with a high absorption rate for arsenic. It can end up with 10 times more of the metal than other grains. Because rice cereal is usually one of the first solid foods given to babies, it can have a significant impact on development.

Babies may eat multiple servings of rice cereal in a day, which can lead to exposure to inorganic arsenic, which is toxic. It can damage the neurodevelopmental system and harm their IQ.

Arsenic in rice cereal isn’t a new issue. Testing revealed that over 60 percent of rice cereals and other products have arsenic in them back in 2012. Since then, agencies have called for limits on the amount found in these products. Now, eight years later, the FDA has determined a limit of 100 parts per billion for arsenic in infant rice cereal. Other agencies have called for a lower limit.

While this limit is important news to manufacturers of baby cereal, it’s not enforceable. It is voluntary for manufacturers to follow these guidelines. The FDA conducted tests in 2018 on baby rice cereals, looking at the amount of arsenic present. About three-fourths of the products were at or below the new 100 ppb limit.

While critics believe this is an important first step to controlling the amount of arsenic that enters an infant’s system, they say more still needs to be done. Other products should be included, according to consumers advocates. Apple Juice is another product of concern. Experts believe it should be treated the same as drinking water with a limit of 10 ppb.

The Dangers of Arsenic

According to consumer advocates, limits should be given for all heavy metals, including lead and cadmium. The goal should be lower to reduce risk for children.

Arsenic is a natural element, which means it occurs in nature. It can get into the food supply through the soil as well as in the water and air. Contamination can happen with mining or fracking. Volcanoes that erupt can create an increase in arsenic at the surface of the earth.

Long-term exposure of arsenic has been linked to certain types of cancer and skin disorders. Even short-term exposure can lead to nausea and vomiting and other side effects. Young children have a higher risk for learning and development issues, which is why the FDA monitors products for infants and younger people at a higher rate than with other products.

It is important for parents to be aware of these risks and to determine which products are safest for their children. The effects from exposure to arsenic may not be seen right away, but they may be serious.

Comments
Continue Reading

Trending